Mn Services Vermogensbeheer B.V. Biogen Inc. Transaction History

Mn Services Vermogensbeheer B.V.

$14.3 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	SELL	$222.59 - $267.94 $578,734 - $696,644	-2,600 Reduced 3.72%	67,208 $17.4 Million
Q3 2023 Oct 25, 2023	BUY	$253.3 - $285.89 $253,300 - $285,890	1,000 Added 1.45%	69,808 $17.9 Million
Q2 2023 Aug 09, 2023	SELL	$275.25 - $318.06 $1.27 Million - $1.46 Million	-4,600 Reduced 6.27%	68,808 $19.6 Million
Q1 2023 Apr 26, 2023	BUY	$256.56 - $292.34 $846,648 - $964,721	3,300 Added 4.71%	73,408 $20.4 Million
Q4 2022 Feb 03, 2023	SELL	$252.44 - $306.72 $2.78 Million - $3.37 Million	-11,000 Reduced 13.56%	70,108 $19.4 Million
Q3 2022 Nov 01, 2022	SELL	$194.69 - $268.46 $1.01 Million - $1.4 Million	-5,200 Reduced 6.02%	81,108 $21.7 Million
Q2 2022 Aug 03, 2022	SELL	$187.54 - $223.02 $4.16 Million - $4.95 Million	-22,200 Reduced 20.46%	86,308 $17.6 Million
Q1 2022 May 10, 2022	SELL	$193.77 - $244.14 $1.49 Million - $1.88 Million	-7,700 Reduced 6.63%	108,508 $22.9 Million
Q4 2021 Feb 10, 2022	BUY	$223.92 - $287.77 $626,976 - $805,756	2,800 Added 2.47%	116,208 $27.9 Million
Q3 2021 Nov 03, 2021	BUY	$282.99 - $369.05 $481,083 - $627,385	1,700 Added 1.52%	113,408 $32.1 Million
Q2 2021 Aug 05, 2021	SELL	$259.0 - $414.71 $10.5 Million - $16.9 Million	-40,700 Reduced 26.7%	111,708 $32.6 Million
Q4 2020 Feb 09, 2021	BUY	$236.26 - $355.63 $259,886 - $391,193	1,100 Added 0.73%	152,408 $37.3 Million
Q3 2020 Nov 04, 2020	BUY	$264.77 - $305.71 $767,833 - $886,558	2,900 Added 1.95%	151,308 $42.9 Million
Q2 2020 Jul 23, 2020	SELL	$258.66 - $342.55 $5.1 Million - $6.75 Million	-19,700 Reduced 11.72%	148,408 $39.7 Million
Q1 2020 May 12, 2020	SELL	$268.85 - $341.04 $2.9 Million - $3.68 Million	-10,800 Reduced 6.04%	168,108 $53.2 Million
Q4 2019 Feb 12, 2020	BUY	$220.06 - $304.07 $1.03 Million - $1.43 Million	4,700 Added 2.7%	178,908 $53.1 Million
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $16 Million - $17.9 Million	73,535 Added 73.04%	174,208 $40.6 Million
Q2 2019 Jul 25, 2019	SELL	$219.29 - $241.72 $3.16 Million - $3.48 Million	-14,400 Reduced 12.51%	100,673 $23.5 Million
Q1 2019 May 06, 2019	BUY	$216.71 - $338.96 $238,381 - $372,856	1,100 Added 0.97%	115,073 $27.2 Million
Q4 2018 Feb 12, 2019	BUY	$278.5 - $352.75 $22.4 Million - $28.3 Million	80,308 Added 238.55%	113,973 $30 Million
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $103,008 - $122,764	400 Added 1.2%	33,665 $9.77 Million
Q1 2018 May 11, 2018	BUY	$260.13 - $367.91 $104,052 - $147,164	400 Added 1.22%	33,265 $9.11 Million
Q4 2017 Feb 02, 2018	SELL	$307.64 - $344.58 $738,336 - $826,992	-2,400 Reduced 6.81%	32,865 $8.72 Million
Q3 2017 Nov 01, 2017	BUY	$281.15 - $329.69 $9.91 Million - $11.6 Million	35,265	35,265 $11 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mn Services Vermogensbeheer B.V., based on Form 13F filings with the SEC.

News

Stay updated on Mn Services Vermogensbeheer B.V. with notifications on news.

Account